Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Toronto Dominion Bank
TD
|
+$441M |
| 2 |
Brookfield
BN
|
+$350M |
| 3 |
Royal Bank of Canada
RY
|
+$335M |
| 4 |
Manulife Financial
MFC
|
+$281M |
| 5 |
Scotiabank
BNS
|
+$276M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$788M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$492M |
| 3 |
Blackstone
BX
|
+$441M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$406M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$405M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.57% |
| 2 | Technology | 10.16% |
| 3 | Energy | 9.49% |
| 4 | Miscellaneous | 8.69% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3651
CryoPort
CYRX
$879M
| $47K | ﹤0.01% |
2,862
+561
| +24% | +$11.2K |
2017 Q4
7 quarters
|
|
3652
TG Therapeutics
TGTX
$8.21B
| $47K | ﹤0.01% |
8,427
+284
| +3% | +$1.98K |
2017 Q4
7 quarters
|
|
3653
Teekay
TK
$1.28B
| $47K | ﹤0.01% |
11,737
+3,290
| +39% | +$13.2K |
2019 Q2
1 quarter
|
|
|
YMAB
3654
DELISTED
Y-mAbs Therapeutics
YMAB
| $47K | ﹤0.01% |
1,788
+79
| +5% | +$2.02K |
2019 Q2
1 quarter
|
|
|
CNR
3655
Core Natural Resources Inc
CNR
$4.35B
| $47K | ﹤0.01% |
3,021
-768
| -20% | -$15K |
2017 Q4
7 quarters
|
|
|
FBMS
3656
DELISTED
The First Bancshares, Inc.
FBMS
| $47K | ﹤0.01% |
1,455
+56
| +4% | +$1.78K |
2019 Q2
1 quarter
|
|
|
ATRS
3657
DELISTED
Antares Pharma, Inc.
ATRS
| $47K | ﹤0.01% |
14,190
+530
| +4% | +$1.75K |
2019 Q2
1 quarter
|
|
|
AMAG
3658
DELISTED
AMAG Pharmaceuticals
AMAG
| $47K | ﹤0.01% |
4,046
+837
| +26% | +$8.81K |
2013 Q2
25 quarters
|
|
|
BITA
3659
DELISTED
Bitauto Holdings Limited
BITA
| $47K | ﹤0.01% |
3,138
-5,488
| -64% | -$67.2K |
2013 Q3
24 quarters
|
|
|
PEI
3660
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $47K | ﹤0.01% |
545
-169
| -24% | -$14.3K |
2013 Q2
25 quarters
|
|
3661
Farmers National Banc Corp
FMNB
$898M
| $46K | ﹤0.01% |
3,132
+70
| +2% | +$998 |
2016 Q4
11 quarters
|
|
3662
Kura Oncology
KURA
$947M
| $46K | ﹤0.01% |
3,010
+545
| +22% | +$9.7K |
2017 Q3
8 quarters
|
|
3663
Quad
QUAD
$478M
| $46K | ﹤0.01% |
4,297
-2,236
| -34% | -$20.9K |
2013 Q2
25 quarters
|
|
3664
UroGen Pharma
URGN
$1.98B
| $46K | ﹤0.01% |
1,936
+372
| +24% | +$12.2K |
2019 Q2
1 quarter
|
|
|
XENT
3665
DELISTED
Intersect ENT, Inc
XENT
| $46K | ﹤0.01% |
2,694
+118
| +5% | +$2.15K |
2017 Q4
7 quarters
|
|
|
JCAP
3666
DELISTED
Jernigan Capital, Inc.
JCAP
| $46K | ﹤0.01% |
2,404
-9,026
| -79% | -$179K |
2018 Q2
5 quarters
|
|
3667
Axsome Therapeutics
AXSM
$9.54B
| $45K | ﹤0.01% |
2,207
+174
| +9% | +$4.47K |
2019 Q2
1 quarter
|
|
3668
Digimarc Corp
DMRC
$152M
| $45K | ﹤0.01% |
1,152
+60
| +5% | +$2.59K |
2015 Q4
15 quarters
|
|
3669
Ennis
EBF
$570M
| $45K | ﹤0.01% |
2,254
+98
| +5% | +$1.98K |
2017 Q2
9 quarters
|
|
3670
iShares MSCI Emerging Markets Asia ETF
EEMA
$893M
| $45K | ﹤0.01% |
709
-60,181
| -99% | -$3.84M |
2015 Q2
17 quarters
|
|
3671
MicroSectors FANG+ Index 2X Leveraged ETNs due 8 Jan 2038
FNGO
$788M
| $45K | ﹤0.01% |
6,075
-5,720
| -48% | -$44.4K |
2018 Q3
4 quarters
|
|
3672
Forrester Research
FORR
$221M
| $45K | ﹤0.01% |
1,397
-401
| -22% | -$15.9K |
2013 Q2
25 quarters
|
|
|
HTBK
3673
DELISTED
Heritage Commerce
HTBK
| $45K | ﹤0.01% |
3,817
+282
| +8% | +$3.35K |
2015 Q4
15 quarters
|
|
3674
nLIGHT
LASR
$2.3B
| $45K | ﹤0.01% |
2,899
+182
| +7% | +$2.82K |
2019 Q2
1 quarter
|
|
3675
iShares MSCI China ETF
MCHI
$6B
| $45K | ﹤0.01% |
800
+100
| +14% | +$5.76K |
2018 Q3
4 quarters
|
|
Similar funds
Bank of Montreal's Q3 2019 Portfolio in Review
As of Q3 2019, Bank of Montreal held 5,215 positions worth $116B, down 2.6% from $119B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of Montreal's Q3 2019 filing shows 284 new, 2,531 increased, 1,518 reduced and 466 closed positions. Its largest new stake was Vanguard Energy ETF: 426,934 shares worth $33.3M. The largest sale was Altaba Inc, an estimated $788M.
By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 25% a quarter earlier, followed by Technology and Energy.
- Bank of Montreal's largest Q3 2019 buy was Vanguard Energy ETF: 426,934 shares worth $33.3M.
- Bank of Montreal added most to Toronto Dominion Bank in Q3 2019, an estimated $441M increase.
- Bank of Montreal's biggest Q3 2019 reduction was Altaba Inc, cutting an estimated $788M.
- Bank of Montreal fully exited Andeavor Logistics LP in Q3 2019, selling an estimated $115M.
- Bank of Montreal's ten largest holdings make up 21% of its $116B portfolio in Q3 2019.
- Bank of Montreal opened 284 new positions and closed 466 in Q3 2019.
- Bank of Montreal's portfolio value fell 2.6% quarter-over-quarter to $116B.
Based on Bank of Montreal's 13F filing for Q3 2019, filed 8 Nov 2019.